Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Core Insights - Galderma conducted a global survey revealing that over 50% of peri- and post-menopausal women learned about menopause's effects on skin through personal experience, primarily in their 40s, with over 30% wishing they had known in their 30s [1][2][4] Group 1: Survey Findings - The survey included over 4,300 women aged 45-60 from nine countries, highlighting that women experienced an average of three skin changes since menopause, with 59% reporting lines and wrinkles on the face and 33% on the body [6][12] - The main skin changes reported were loss of firmness and elasticity (58% on the face, 54% on the body), increased dryness (56% on the face, 58% on the body), and a duller skin tone (40% on the face, 30% on the body) [6][7] Group 2: Impact on Wellbeing - The survey indicated that menopause-related skin changes negatively impacted women's self-perception, with 60% feeling less attractive, 57% feeling anxious, and 55% feeling less confident [4][12] - Aesthetic treatments were viewed as effective solutions, with 49% of women currently using them for menopause-related skin changes, while 26% used them for prevention [12] Group 3: Aesthetic Treatments - Galderma plans to include menopausal status in clinical trials to better understand how injectable aesthetic treatments can address menopause-related skin changes [2][5] - Treatments such as hyaluronic acid and biostimulators are highlighted for their potential to enhance hydration, restore collagen and elastin, and improve skin quality [5][9] Group 4: Company Commitment - Galderma aims to elevate awareness and advance aesthetic solutions for menopause-related skin changes through collaboration with experts and community education [8][10] - The company is positioned as a leader in dermatology, focusing on innovative, science-based solutions to meet the needs of women during menopause [10][8]